Invesco Pharmaceuticals ETF
PJP
89 hedge funds and large institutions have $65.8M invested in Invesco Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 10 closing their positions.
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
2% more funds holding
Funds holding: 87 → 89 (+2)
3.27% less ownership
Funds ownership: 21.5% → 18.22% (-3.3%)
12% less capital invested
Capital invested by funds: $75.1M → $65.8M (-$9.27M)
28% less call options, than puts
Call options by funds: $2.56M | Put options by funds: $3.57M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.92M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.35M |
| 3 |
Morgan Stanley
New York
|
+$678K |
| 4 |
Citigroup
New York
|
+$409K |
| 5 |
LPL Financial
San Diego,
California
|
+$303K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWMS
Advocacy Wealth Management Services
Atlanta,
Georgia
|
-$7.41M |
| 2 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$6.76M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$2.94M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.39M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.33M |
PJP Hedge Fund Activity: Q1 2021 in Review
89 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2021, worth a combined $65.8M — down 12% from $75.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PJP positions and 10 closed out — a net gain of 2 holders — while 24 added to existing stakes and 21 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $1.92M. The largest seller was Advocacy Wealth Management Services, cutting an estimated $7.41M.
- 89 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2021, up from 87 in Q4 2020.
- Funds reported $65.8M of Invesco Pharmaceuticals ETF stock for Q1 2021, down 12% quarter-over-quarter.
- 12 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2021 and 10 closed out, a net change of +2 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2021 was Credit Suisse, an estimated $1.92M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2021 was Advocacy Wealth Management Services, an estimated $7.41M sold.
Based on aggregated 13F filings for Q1 2021.